Christine H Chung, David Raben. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useBiomarkers, Tumor/analysisCarcinoma, Squamous Cell/chemistryCarcinoma, Squamous Cell/mortalityCarcinoma, Squamous Cell/pathologyCarcinoma, Squamous Cell/therapyCarcinoma, Squamous Cell/virologyCell HypoxiaChemotherapy, AdjuvantCisplatin/administration & dosageCyclin-Dependent Kinase Inhibitor p16/analysisDNA, Viral/analysisDisease-Free SurvivalHumansNeoplasm Recurrence, Local/prevention & controlNeoplasm StagingOropharyngeal Neoplasms/chemistryOropharyngeal Neoplasms/mortalityOropharyngeal Neoplasms/pathologyOropharyngeal Neoplasms/therapyOropharyngeal Neoplasms/virologyPapillomaviridae/geneticsRadiotherapy, AdjuvantRisk AssessmentRisk FactorsTime FactorsTirapazamineTreatment OutcomeTriazines/administration & dosage
Substances： See more » Biomarkers, TumorCyclin-Dependent Kinase Inhibitor p16DNA, ViralTriazinesTirapazamineCisplatin
Year: 2010 PMID： 20697096 DOI： 10.1200/JCO.2010.30.6035
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544